CD63 and hematocrit: To investigate whether tissue sEVs are involved in the pathogenesis of HT, tissue sEVs were first isolated and validated via NTA (Fig. 1A), TEM (Fig. 1B), and the expression of the positive markers TSG101, HSP70, and CD63 without the expression of the negative marker calnexin (Fig. 1C).